Impact of a Letter Encouraging Pneumococcal Vaccination on the 1-year Vaccination Rate in Heart Failure Patients With a Primary Care Physician
NCT ID: NCT06360315
Last Updated: 2024-04-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
12000 participants
INTERVENTIONAL
2023-01-02
2024-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vaccination Against Influenza Pre-discharge in Heart Failure
NCT06725927
Flu Vaccination in Congestive Heart Failure
NCT00664339
Prevention of Early Readmission in Elderly Congestive Heart Failure Patients
NCT00000475
Implementing a Digitally-enabled Community Health Worker Intervention for Patients With Heart Failure
NCT05130008
SAFEty and Efficacy of HOME-based Hospitalization Versus Inpatient Care for Patients With Acute Heart Failure in Chronic Heart Failure.
NCT03156686
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Incentive letter for pneumococcal vaccination to the patient and to the GP
Incentive letter for pneumococcal vaccination to the patient and to the GP
Incentive letter for pneumococcal vaccination to the patient and to the GP
No letter sent
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Incentive letter for pneumococcal vaccination to the patient and to the GP
Incentive letter for pneumococcal vaccination to the patient and to the GP
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Residing in the Occitanie region, France
* With heart failure registered as ALD
* Who have declared an attending physician
* Who have not received a pneumococcal vaccination for more than 24 months (due to the length of time available in the database)
Exclusion Criteria
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Montpellier University Hospital
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
202201265
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.